Gouya Insights Publications

This is a list Gouya Insights Publications from most recent to oldest. If you’re looking for work we’ve done, please visit our Portfolio page.

JUL 2020

Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans.

Samekova K, Firbas C, Irrgeher J, Opper C, Prohaska T, Retzmann A, Tschegg C, Meisslitzer C, Tchaikovsky A, Gouya G, Freissmuth M, Wolzt M. Sci Rep. 2021 Jul 20;11(1):14796.

AUG 2020

Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid dependent males-a-double-blinded, randomized study.

Weisshaar S, Brandt L, Litschauer B, Sheikh-Rezaei S, Moser L, Nirnberger G, Kühlberger E, Bauer U, Firbas C, Gouya G, Wolzt M, Fischer G. Br J Clin Pharmacol. 2020 Aug,86(8):1610-1619.

JAN 2019

ADMA and NT pro-BNP are associated with overall mortality in elderly.

Sheikh Rezaei S, Weisshaar S, Litschauer B, Gouya G, Ohrenberger G, Wolzt M. ADMA and NT pro-BNP are associated with overall mortality in elderly. Eur J Clin Invest. 2019 Jan;49(1):e13041.

JUN 2018

Cardiovascular Effects of Stress During Acutely Increased Free Fatty Acids in a Randomized, Double-Blind, Cross-Over Study in Humans.

Rezaei SS, Litschauer B, Gouya G, Baumgartner-Parzer S, Stulnig T, Wolzt M. Cardiovascular Effects of Stress During Acutely Increased Free Fatty Acids in a Randomized, Double-Blind, Cross-Over Study in Humans. Horm Metab Res. 2018 Jun;50(6):478-484. doi: 10.1055/a-0620-8438. Epub 2018 Jun 8. PubMed PMID: 29883974.

JUL 2017

Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I).

Simader E, Traxler D, Kasiri MM, Hofbauer H, Wolzt M, Glogner C, Storka A, Mildner M, Gouya G, Geusau A, Fuchs C, Eder C, Graf A, Schaden M, Golabi B, Aretin MB, Suessner S, Gabriel C, Klepetko W, Tschachler E, Ankersmit HJ. Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I). Sci Rep. 2017 Jul 24;7(1):6216.

OCT 2015

A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.

Mesgarpour B, Gouya G, Herkner H, Reichardt B, Wolzt M. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death. Lipids Health Dis. 2015 Oct 24;14:131.

JAN 2015

Comparison of pharmacokinetic and safety profiles between Bemfola(R) and Gonal-f (R) after subcutaneous application.

Wolzt M, Gouya G, Sator M, Hemetsberger T, Irps C, Rettenbacher M, Vcelar B. Comparison of pharmacokinetic and safety profiles between Bemfola(R) and Gonal-f (R) after subcutaneous application. Eur J Drug Metab Pharmacokinet. 2015 Jan 30.

JAN 2015

Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.

Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Bolger G, Helson L, Wolzt M. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther. 2015 Jan;53(1):54-65.

FEB 2014

Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.

Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FWA, Gurbel PA, Pirker-Kees A., Siller-Matula J. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke. 2014 Feb;45(2):492-503.

APR 2014

Effect of systemic high dose vitamin C therapy on forearm blood flow reactivity during endotoxemia in healthy human subjects.

Aschauer S, Gouya G, Klickovic U, Storka A, Weisshaar S, Vollbracht C, Krick B, Weiss G, Wolzt M. Effect of systemic high dose vitamin C therapy on forearm blood flow reactivity during endotoxemia in healthy human subjects. Vascul Pharmacol. 2014 Apr;61(1):25-9.

APR 2014

Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans.

Told R, Palkovits S, Schmidl D, Boltz A, Gouya G, Wolzt M, Napora KJ, Werkmeister R, Popa-Cherecheanu A, Garhfer G, Schmetterer L. Retinal hemodynamic effects of antioxidant supplementation in an endotoxin-induced model of oxidative stress in humans. Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2220-7.

NOV 2014

Association of Nutritional Risk Index with Metabolic Biomarkers, Appetite-Regulatory Hormones, and Inflammatory Biomarkers and Outcome in Patients with Chronic Heart Failure.

Gouya G, Voithofer P, Neuhold S, Storka A, Vila G, Pacher R, Wolzt M, Huelsmann M. Association of Nutritional Risk Index with Metabolic Biomarkers, Appetite-Regulatory Hormones, and Inflammatory Biomarkers and Outcome in Patients with Chronic Heart Failure. IJCP 2014 Nov; 68(11):1293-300.

DEC 2014

Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model.

Told R, Schmidl D, Palkovits S, Boltz A, Gouya G, Wolzt M, WitkowskaKJ, Popa-Cherecheanu A, Werkmeister RM, Garhfer G, Schmetterer L. Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model. Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):403-11.

2014

Human Pharmacokinetics of High Dose Oral Curcumin and Its Effect on Heme Oxygenase-1 (Ho-1 Expression) in Healthy Male Subjects.

Klickovic U, Doberer D, Gouya G, Aschauer S, Weisshaar S, Storka A, Bilban M, Wolzt M. Human Pharmacokinetics of High Dose Oral Curcumin and Its Effect on Heme Oxygenase-1 (Ho-1 Expression) in Healthy Male Subjects. Biomed Res Int. 2014;2014:458592.

JUL 2013

The LPS-induced increase in circulating microparticles is not affected by vitamin C in humans.

Weisshaar S, Gouya G, Nguyen D, Kapiotis S, Wolzt M. TheLPS-induced increase in circulating microparticles is not affected by vitamin C in humans. Eur J Clin Invest. 2013 Jul;43(7):708-15.

JUL 2013

The LPS-induced increase in circulating microparticles is not affected by vitamin C in humans.

Weisshaar S, Gouya G, Nguyen D, Kapiotis S, Wolzt M. TheLPS-induced increase in circulating microparticles is not affected by vitamin C in humans. Eur J Clin Invest. 2013 Jul;43(7):708-15.

AUG 2013

Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber.

Wolzt M, Gouya G, Kapiotis S, BeckaM, Mueck W, Kubitza D. Open-label, randomized study of the effect of rivaroxaban with or without acetylsalicylic acid on thrombus formation in a perfusion chamber. Thromb Res. 2013 Aug;132(2):240-7.

SEP 2013

Effect of liposomal curcumin on red blood cells in vitro.

Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Helson L, Wolzt M. Effect of liposomal curcumin on red blood cells in vitro. Anticancer Res. 2013 Sep;33(9):3629-34.

SEP 2013

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study.

Siller-Matula JM, Francesconi M, Dechant C, Jilma B, Maurer G, Delle-Karth G, Gouya G, Ruzicka K, Podczeck-Schweighofer A, Christ G. Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study. Int J Cardiol. 2013 Sep 1;167(5):2018-23.

NOV 2013

Association of Endostatin with Mortality in Patients with Chronic Heart Failure.

Gouya G., Siller-Matula J., Fritzer-Szekeres M., Neuhold S., Storka A., Neuhofer LM, Clodi M., Hlsmann M., Pacher R., Wolzt M. Association of Endostatin with Mortality in Patients with Chronic Heart Failure. Eur J Clin Invest. 2013 Nov 5.

APR 2012

Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists.

Wolzt M, Eriksson UG, Gouya G, Leuchten N, Kapiotis S, Elg M, Schtzer KM, Zetterstrand S, Holmberg M, Whlander K. Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists. Thromb Res. 2012 Apr;129(4):e83-91.

MAY 2012

Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase.

Schaller G, Dittrich P, Felizeter M, Gouya G, Leuchten N, Kapiotis S, Vcelar B, Vorauer-Uhl K, Wolzt M. Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase. Int J Clin Pharmacol Ther. 2012 May 22;Volume 50(June):413-417.

NOV 2012

Comparative bioactivity of subcutaneous low molecular weight heparin in critically ill patients with normal renal function.

Gouya G, Palkovits S, Kapiotis S, Madl C, Locker G, Stella A, Wolzt M, Heinz G. Comparative bioactivity of subcutaneous low molecular weight heparin in critically ill patients with normal renal function. Brit J Clin Pharm. 2012 Nov;74(5):806-14.

MAR 2011

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Gouya G, Sturm G, Lamina C, Zitt E, Freisttter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, and Kronenberg F. The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort. PLoS One. 2011 Mar 7;6(3):e17803.

AUG 2011

Benefit of specialized clinics for the treatment of patients with heart failure.

Gouya G, Hammer A, Elhenicky M, Neuhold S, Wolzt M, Hlsmann M, Pacher R. Benefit of specialized clinics for the treatment of patients with heart failure. Eur J Intern Med. 2011 Aug;22(4):428-31.

FEB 2010

Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial.

Heinisch BB, Francesconi M, Mittermayer F, Schaller G, Gouya G, Wolzt M, Pleiner J. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Eur J Clin Invest. 2010 Feb;40(2):148-54.

JAN 2010

Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy.

Neuhold S, Huelsmann M, Strunk G, Struck J, Adlbrecht C, Gouya G, Elhenicky M, Pacher R. Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy. Clin Chem. 2010 Jan;56(1):121-6.

JAN 2010

Alcohol Acutely Increases Vascular Reactivity together with Insulin Sensitivity in Type 2 Diabetic Men.

Schaller G, Kretschmer S, Gouya G, Haider DG, Mittermayer F, Riedl M, Wagner O, Pacini G, Wolzt M, Ludvik B. Alcohol Acutely Increases Vascular Reactivity together with Insulin Sensitivity in Type 2 Diabetic Men. Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):57-60.

AUG 2009

Cross validation of the Multiple Electrode Aggregometry.

Siller-Matula JM, Gouya G, Wolzt M, Jilma B. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thromb Haemost. 2009 Aug;102(2):397-403.

MAY 2009

Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial.

Gouya G, Jilma B, Niel M, Eichelberger B, Wolzt M, Panzer S. Cross validation of aspirin effect ni healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial. Platelets. 2009 May;20(3):171-6.

2008

Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients.

Gouya G, Reichardt B, Bidner A, Weissenfels R, Wolzt M. [Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients]. Wien Klin Wochenschr. 2008;120(3-4):89-95.

2007

Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy.

Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22(3):145-9.

2007

Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy.

Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22(3):145-9.

MAR 2007

Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care-an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.

Risch L, Saely CH, Neyer U, Hoefle G, Gouya G, Zerlauth M, Risch GM, Risch M, Drexel H. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care-an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clin Chim Acta. 2007 Mar;378(1-2):71-7.

DEC 2006

C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.

Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L, Kapiotis S, Wolzt M. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol. 2006 Dec; 146(3):533-9.

SEP 2006

Sex-specific antihypertensive drug therapy.

Phringer P, Gouya G, Reichardt B, Wolzt M. Sex-specific antihypertensive drug therapy. Wien Med Wochenschr. 2006 Sep;156(17-18):498-500.

FEB 2007

Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function.

Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S, Drexel H. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta.2007 Feb;376(1-2):108-13.

NOV 2006

Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum.

Risch L, Hoefle G, Saely C, Berchthold S, Weber M, Gouya G, Rein P, Langer P, Marte T, Aczel S, Drexel H. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin Chim Acta. 2006 Nov;373(1-2):121-6.

JUL 2003

Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone.

Hfle G, Holzmller H, Gouya G, Hergan K, Hubmann M, Langer P, Drexel H. Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone. Transpl Int. 2003 Jul;16(7):523-8.

OCT 2002

Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic.

Plzl G, Gouya G, Hgel H, Frick M, Ulmer H, Pachinger O. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic]. Wien Klin Wochenschr. 2002 Oct 31;114(19-20):833-9.

MAR 1997

The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man.

Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Findl O, Lexer F, Breiteneder H, Fercher AF, Eichler HG. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res. 1997 Mar;64(3):305-12.

DEC 1995

The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men.

Schmetterer L, Wolzt M, Lexer F, Alschinger C, Gouya G, Zanaschka G, Fassolt A, Eichler HG, Fercher AF. The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men. Exp Eye Res. 1995 Dec;61(6):685-90.

OCT 1995

Is the ECG measure RSh a promising technique for detecting class I antiarrhythmic drug action in men.

Wolzt M, Schmetterer L, Gouya G, Zanaschka G, EichlerHG. Is the ECG measure RSh a promising technique for detecting class I antiarrhythmic drug action in men J Cardiovasc Pharmacol. 1995 Oct;26(4):660-5.

Case Reports, Editorials and Reviews:

MAR 2006

A case of fulminant post-transplant lymphoproliferative disorder and septicemia. Clin Transplant.

Gouya G, Hartmann G, Fa P, Tauber M, Holzmller H, Benzer W, Lang A, Schuster A, Drexel H, Offner FA. A case of fulminant post-transplant lymphoproliferative disorder and septicemia. Clin Transplant. 2006 Mar-Apr;20(2):261-4.

JUN 2009

Eine Folge der chronischen Herzinsuffizienz. Wiener Klinisches Magazin.

Gouya G, Hlsmann M. Die kardiale Kachexie. Eine Folge der chronischen Herzinsuffizienz. Wiener Klinisches Magazin. Volume 12, Number 3 / Juni 2009.

Book Chapters

2008

Rationelle Abklrung des Hypertonikers und Risikostratifizierung.

Gouya G, Wolzt M: Rationelle Abklrung des Hypertonikers und Risikostratifizierung. In: Auer J (ed), Hypertoniebehandlung in der Praxis. UNI-MED Verlag AG, ISBN 978-3-8374-1081-5, 2008.

2010

Current Topics in Clinical Pharmacology.

Gouya G. Current Topics in Clinical Pharmacology (Mller M. et al); Special situations, market fragmentation 2: sex – differences; Example: CHD. Springer Verlag 2010-revised 2016.

2012

Schmetterer L (ed), Ocular Blood Flow.

Gouya G, Wolzt M: Cardiovascular disease and ocular manifestations. In: Schmetterer L (ed), Ocular Blood Flow. Springer, Berlin 2012.